Published online Aug 21, 2026. doi: 10.3748/wjg.119570
Revised: April 8, 2026
Accepted: May 18, 2026
Published online: August 21, 2026
Processing time: 185 Days and 13.5 Hours
Acute pancreatitis (AP) is an inflammatory disease with a complex pathogenesis. A subset of cases is closely associated with hypertriglyceridemia (HTG). Apolipoprotein C3 (ApoC3) is a key regulator of lipid metabolism in circulation, and previous studies primarily focus on its roles in metabolic diseases such as atherosclerosis and metabolic dysfunction-associated steatotic liver disease. However, its impact on HTG-associated AP has not been fully clarified.
To investigate ApoC3’s role in AP under different lipotoxic conditions and to as
ApoC3 knockout (ApoC3-/-) hamsters and mice were generated, and three AP models were established: Caerulein-induced AP, ethanol plus palmitoleic acid [ethanol (EtOH) + palmitoleic acid (POA)]-induced AP, and a high-fat diet (HFD) combined with caerulein (HFD + caerulein)-induced AP. Multiple parameters were evaluated, including plasma lipid levels, pancreatic enzyme activity, histological damage scores, expression of inflammatory markers, and immune cell infiltration.
In the caerulein-induced AP model, loss of ApoC3 did not confer significant protection in mice. However, in hamsters, ApoC3 deficiency significantly reduced plasma triglyceride and nonesterified fatty acid levels, attenuated the elevated levels of pancreatic enzymes and tissue injury, downregulated the mRNA expression of pro-inflammatory and pro-apoptotic genes such as Tnf-α, interleukin-6, interleukin-18, Nlrp3, and Bax, and reduced infiltration of myeloperoxidase-positive neutrophils and cluster of differentiation 68-positive macrophages. Moreover, these beneficial effects were also observed in ApoC3-/- hamsters with AP induced by EtOH + POA or HFD + caerulein, suggesting that ApoC3 plays a pathogenic role under various lipotoxic conditions.
ApoC3 promotes HTG-associated AP. Its deficiency protects against AP by improving lipid profiles, reducing inflammation and apoptosis, and alleviating pancreatic injury, supporting therapeutic targeting.
Core Tip: Hypertriglyceridemia (HTG) has been shown to cause acute pancreatitis (AP), but the mechanisms remain unclear. This study identified apolipoprotein C3 (ApoC3) as a key player in AP pathogenesis. In three hamster AP models, ApoC3 deficiency significantly reduced pancreatic injury by improving lipid metabolism, suppressing inflammatory cytokine production, and limiting immune cell infiltration. In contrast, ApoC3 deficiency showed no protective effect in mice, underscoring the importance of appropriate model selection. Our findings establish ApoC3 as a critical molecular bridge between dyslipidemia and pancreatic inflammation, highlighting its potential as a novel therapeutic target for HTG-related AP.